Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BILLION: Bivalirudin vs UFH in long coronary lesions
NCT01555658Phase 3Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Apr 2012
- Primary completion
- Sep 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bivalirudin in coronary artery disease (CAD), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
bivalirudin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01555658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555658.